EFFECT OF BLOOD PRODUCT MEDIUM SUPPLEMENTS ON THE ACTIVITY OF CEFOTAXIME AND OTHER CEPHALOSPORINS AGAINST ENTEROCOCCUS-FAECALIS

被引:10
作者
ELIOPOULOS, GM
REISZNER, E
WILLEY, S
NOVICK, WJ
MOELLERING, RC
机构
[1] HARVARD UNIV,SCH MED,DEPT MED,BOSTON,MA 02115
[2] HARVARD UNIV,SCH MED,NEW ENGLAND MED SCH,BOSTON,MA 02115
[3] HOECHST ROUSSEL PHARMACEUT INC,SOMERVILLE,NJ 08876
关键词
D O I
10.1016/0732-8893(89)90006-0
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页码:149 / 156
页数:8
相关论文
共 21 条
[1]  
ANHALT JP, 1985, MANUAL CLIN MICROBIO, P1009
[2]  
BONNER WM, 1974, EUR J BIOCHEM, V46, P83
[3]   ENTEROCOCCAL SUPERINFECTION AND COLONIZATION WITH AZTREONAM THERAPY [J].
CHANDRASEKAR, PH ;
SMITH, BR ;
LEFROCK, JL ;
CARR, B .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1984, 26 (02) :280-282
[4]   CHARACTERIZATION OF BINDING OF HUMAN ALPHA-2-MACROGLOBULIN TO GROUP-G STREPTOCOCCI [J].
CHHATWAL, GS ;
MULLER, HP ;
BLOBEL, H .
INFECTION AND IMMUNITY, 1983, 41 (03) :959-964
[5]   BINDING OF STREPTOCOCCAL LIPOTEICHOIC ACID TO FATTY ACID-BINDING SITES ON HUMAN-PLASMA FIBRONECTIN [J].
COURTNEY, HS ;
SIMPSON, WA ;
BEACHEY, EH .
JOURNAL OF BACTERIOLOGY, 1983, 153 (02) :763-770
[6]   RESISTANCE TO BETA-LACTAM ANTIBIOTICS IN STREPTOCOCCUS-FAECIUM [J].
ELIOPOULOS, GM ;
WENNERSTEN, C ;
MOELLERING, RC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1982, 22 (02) :295-301
[8]  
LOUIE TJ, 1977, J INFECT DIS S, V1315, pS18
[9]  
MAIS A, 1984, J NUTR, V114, P75
[10]  
MOELLERING R C JR, 1984, Diagnostic Microbiology and Infectious Disease, V2, p85S